Genetic factors and manganese-induced neurotoxicity

Frontiers in Genetics

Volumn 5, Issue AUG, 2014, Pages

  Chen, Pan ^a   Parmalee, Nancy ^a   Aschner, Michael ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Manganese; Manganism; Neurotoxicity; Parkinson's disease

Indexed keywords

ADENOSINE TRIPHOSPHATASE; ALPHA SYNUCLEIN; AROMATIC LEVO AMINO ACID DECARBOXYLASE; CALCIUM CHANNEL; DJ 1 PROTEIN; DOPAMINE TRANSPORTER; FERROPORTIN; LEUCINE RICH REPEAT KINASE 2; MANGANESE; NATURAL RESISTANCE ASSOCIATED MACROPHAGE PROTEIN 2; NUCLEAR RECEPTOR RELATED FACTOR 1; PARKIN; PINK1 PROTEIN; PROTEIN; PROTEIN ATP 13A2; PROTEIN ZIP 8; UBIQUITIN CARBOXY TERMINAL HYDROLASE L1; UNCLASSIFIED DRUG; VESICULAR MONOAMINE TRANSPORTER 2; ZINC TRANSPORTER;

ENVIRONMENTAL FACTOR; GENE; GENE MUTATION; HEREDITY; HOMEOSTASIS; HUMAN; MILD HEPATIC IMPAIRMENT; NERVE DEGENERATION; NEUROTOXICITY; PARKINSON DISEASE; PROTEIN AGGREGATION; PROTEIN LOCALIZATION; PROTEIN SYNTHESIS REGULATION; SHORT SURVEY; SLC30A10 GENE;

EID: 84906253393     PISSN: None     EISSN: 16648021     Source Type: Journal    
DOI: 10.3389/fgene.2014.00265     Document Type: Short Survey

References (123)

1. Andres-Mateos, E., Perier, C., Zhang, L., Blanchard-Fillion, B., Greco, T. M., Thomas, B.,et al. (2007). DJ-1 gene deletion reveals that DJ-1 is an atypical peroxiredoxin-like peroxidase. Proc. Natl. Acad. Sci. U.S.A. 104, 14807-14812. doi: 10.1073/pnas.0703219104
2. Armstrong, R. A. (2011). Visual symptoms in Parkinson's disease. Parkinsons Dis. 2011:908306. doi: 10.4061/2011/908306
3. Aschner, M. (2000). Manganese: brain transport and emerging research needs. Environ. Health Perspect. 108(Suppl. 3), 429-432. doi: 10.1289/ehp.00108s3429
4. Aschner, M. (2002). Open issues from the 15th International Conference on Manganese. Neurotoxicology 23, 123-125. doi: 10.1016/S0161-813X(01)00097-3
5. Aschner, M., and Gannon, M. (1994). Manganese (Mn) transport across the rat blood-brain barrier: saturable and transferrin-dependent transport mechanisms. Brain Res. Bull. 33, 345-349. doi: 10.1016/0361-9230(94)90204-6
6. ATSDR. (2012). Toxicological Profile for Manganese. Atlanta, GA: U.S. Department of Health and Human Services, Public Service.
7. Au, C., Benedetto, A., Anderson, J., Labrousse, A., Erikson, K., Ewbank, J. J.,et al. (2009). SMF-1, SMF-2, and SMF-3 DMT1 orthologues regulate and are regulated differentially by manganese levels in C. elegans . PLoS ONE 4:e7792. doi: 10.1371/journal.pone.0007792
8. Bäckman, C., Perlmann, T., Wallén, Å., Hoffer, B. J., and Morales, M. (1999). A selective group of dopaminergic neurons express Nurr1 in the adult mouse brain. Brain Res. 851, 125-132. doi: 10.1016/S0006-8993(99)02149-6
9. Bell, J. G., Keen, C. L., and Lonnerdal, B. (1989). Higher retention of manganese in suckling than in adult rats is not due to maturational differences in manganese uptake by rat small intestine. J. Toxicol. Environ. Health 26, 387-398. doi: 10.1080/15287398909531263
10. Benedetto, A., Au, C., and Aschner, M. (2009). Manganese-induced dopaminergic neurodegeneration: insights into mechanisms and genetics shared with Parkinson's disease. Chem. Rev. 109, 4862-4884. doi: 10.1021/cr800536y
11. Benedetto, A., Au, C., Avila, D. S., Milatovic, D., and Aschner, M. (2010). Extracellular dopamine potentiates mn-induced oxidative stress, lifespan reduction, and dopaminergic neurodegeneration in a BLI-3-dependent manner in Caenorhabditis elegans . PLoS Genet. 6:e1001084. doi: 10.1371/journal.pgen.1001084
12. Ben Gedalya, T., Loeb, V., Israeli, E., Altschuler, Y., Selkoe, D. J., and Sharon, R. (2009). α-synuclein and polyunsaturated fatty acids promote clathrin-mediated endocytosis and synaptic vesicle recycling. Traffic 10, 218-234. doi: 10.1111/j.1600-0854.2008.00853.x
13. Björkblom, B., Adilbayeva, A., Maple-Grødem, J., Piston, D., Ökvist, M., Xu, X. M.,et al. (2013). Parkinson disease protein DJ-1 binds metals and protects against metal-induced cytotoxicity. J. Biol. Chem. 288, 22809-22820. doi: 10.1074/jbc.M113.482091
14. Borgstahl, G. E., Parge, H. E., Hickey, M. J., Beyer, W. F. Jr., Hallewell, R. A., and Tainer, J. A. (1992). The structure of human mitochondrial manganese superoxide dismutase reveals a novel tetrameric interface of two 4-helix bundles. Cell 71, 107-118. doi: 10.1016/0092-8674(92)90270-M
15. Bornhorst, J., Chakraborty, S., Meyer, S., Lohren, H., Brinkhaus, S. G., Knight, A. L.,et al. (2014). The effects of pdr1, djr1.1 and pink1 loss in manganese-induced toxicity and the role of α-synuclein in C. elegans . Metallomics 6, 476-490. doi: 10.1039/C3MT00325F
16. Bosomworth, H. J., Thornton, J. K., Coneyworth, L. J., Ford, D., and Valentine, R. A. (2012). Efflux function, tissue-specific expression and intracellular trafficking of the Zn transporter ZnT10 indicate roles in adult Zn homeostasis. Metallomics 4, 771-779. doi: 10.1039/C2MT20088K
17. Burdo, J. R., Menzies, S. L., Simpson, I. A., Garrick, L. M., Garrick, M. D., Dolan, K. G.,et al. (2001a). Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66, 1198-1207. doi: 10.1002/jnr.1256
18. Burdo, J. R., Menzies, S. L., Simpson, I. A., Garrick, L. M., Garrick, M. D., Dolan, K. G.,et al. (2001b). Distribution of divalent metal transporter 1 and metal transport protein 1 in the normal and Belgrade rat. J. Neurosci. Res. 66, 1198-1207. doi: 10.1002/jnr.1256
19. Butterworth, R. F., Spahr, L., Fontaine, S., and Layrargues, G. P. (1995). Manganese toxicity, dopaminergic dysfunction and hepatic encephalopathy. Metab. Brain Dis. 10, 259-267. doi: 10.1007/BF02109357
20. Clark, I. E., Dodson, M. W., Jiang, C., Cao, J. H., Huh, J. R., Seol, J. H.,et al. (2006). Drosophila pink1 is required for mitochondrial function and interacts genetically with parkin. Nature 441, 1162-1166. doi: 10.1038/nature04779
21. Cohn, J. R., and Emmett, E. A. (1978). The excretion of trace metals in human sweat. Ann. Clin. Lab. Sci. 8, 270-275.
22. Couper, J. (1837). On the effects of black oxide manganese when inhaled into the lungs. Brit. Ann. Med. Pharm. Vital Stat. Gen. Sci. 1, 41-42.
23. Criswell, S. R., Perlmutter, J. S., Huang, J. L., Golchin, N., Flores, H. P., Hobson, A.,et al. (2012). Basal ganglia intensity indices and diffusion weighted imaging in manganese-exposed welders. Occup. Environ. Med. 69, 437-443. doi: 10.1136/oemed-2011-100119
24. Crossgrove, J. S., Allen, D. D., Bukaveckas, B. L., Rhineheimer, S. S., and Yokel, R. A. (2003). Manganese distribution across the blood-brain barrier. I. Evidence for carrier-mediated influx of managanese citrate as well as manganese and manganese transferrin. Neurotoxicology 24, 3-13. doi: 10.1016/S0161-813X(02)00089-X
25. Davis, C. D., Zech, L., and Greger, J. L. (1993). Manganese metabolism in rats: an improved methodology for assessing gut endogenous losses. Proc. Soc. Exp. Biol. Med. 202, 103-108. doi: 10.3181/00379727-202-43518
26. Drahota, Z., Gazzotti, P., Carafoli, E., and Rossi, C. S. (1969). A comparison of the effects of different divalent cations on a number of mitochondrial reactions linked to ion translocation. Arch. Biochem. Biophys. 130, 267-273. doi: 10.1016/0003-9861(69)90033-2
27. Erikson, K., and Aschner, M. (2002). Manganese causes differential regulation of glutamate transporter (GLAST) taurine transporter and metallothionein in cultured rat astrocytes. Neurotoxicology 23, 595-602. doi: 10.1016/S0161-813X(02)00012-8
28. Finley, J. W. (1998). Manganese uptake and release by cultured human hepato-carcinoma (Hep-G2) cells. Biol. Trace Elem. Res. 64, 101-118. doi: 10.1007/BF02783328
29. Finley, J. W., Johnson, P. E., and Johnson, L. K. (1994). Sex affects manganese absorption and retention by humans from a diet adequate in manganese. Am. J. Clin. Nutr. 60, 949-955.
30. Friberg, L., Nordberg, G., and Vouk, V. B. (1979). Handbook on the Toxicology of Metals. Amsterdam: Elsevier/North-Holland Biomedical Press.
31. Frost, G., Asling, C. W., and Nelson, M. M. (1959). Skeletal deformities in manganese-deficient rats. Anat. Rec. 134, 37-53. doi: 10.1002/ar.1091340105
32. Fujishiro, H., Doi, M., Enomoto, S., and Himeno, S. (2011). High sensitivity of RBL-2H3 cells to cadmium and manganese: an implication of the role of ZIP8. Metallomics 3, 710-718. doi: 10.1039/c1mt00020a
33. Garrick, M. D., Dolan, K. G., Horbinski, C., Ghio, A. J., Higgins, D., Porubcin, M.,et al. (2003). DMT1: a mammalian transporter for multiple metals. Biometals 16, 41-54. doi: 10.1023/A:1020702213099
34. Gavin, C. E., Gunter, K. K., and Gunter, T. E. (1990). Manganese and calcium efflux kinetics in brain mitochondria. Relevance to manganese toxicity. Biochem. J. 266, 329-334.
35. Gavin, C. E., Gunter, K. K., and Gunter, T. E. (1999). Manganese and calcium transport in mitochondria: implications for manganese toxicity. Neurotoxicology 20, 445-453.
36. Gitler, A. D., Bevis, B. J., Shorter, J., Strathearn, K. E., Hamamichi, S., Su, L. J.,et al. (2008). The Parkinson's disease protein α-synuclein disrupts cellular Rab homeostasis. Proc. Natl. Acad. Sci. U.S.A. 105, 145-150. doi: 10.1073/pnas.0710685105
37. Gitler, A. D., Chesi, A., Geddie, M. L., Strathearn, K. E., Hamamichi, S., Hill, K. J.,et al. (2009). α-synuclein is part of a diverse and highly conserved interaction network that includes PARK9 and manganese toxicity. Nat. Genet. 41, 308-315. doi: 10.1038/ng.300
38. Gong, B., Cao, Z., Zheng, P., Vitolo, O. V., Liu, S., Staniszewski, A.,et al. (2006). Ubiquitin hydrolase Uch-L1 rescues Β-amyloid-induced decreases in synaptic function and contextual memory. Cell 126, 775-788. doi: 10.1016/j.cell.2006.06.046
39. Grinnell, F. (1984). Manganese-dependent cell-substratum adhesion. J. Cell Sci. 65, 61-72.
40. Gunter, R. E., Puskin, J. S., and Russell, P. R. (1975). Quantitative magnetic resonance studies of manganese uptake by mitochondria. Biophys. J. 15, 319-333. doi: 10.1016/S0006-3495(75)85822-X
41. Gunter, T. E., and Puskin, J. S. (1972). Manganous ion as a spin label in studies of mitochondrial uptake of manganese. Biophys. J. 12, 625-635. doi: 10.1016/S0006-3495(72)86108-3
42. Han, B.-S., Iacovitti, L., Katano, T., Hattori, N., Seol, W., and Kim, K.-S. (2008). Expression of the LRRK2 gene in the midbrain dopaminergic neurons of the substantia nigra. Neurosci. Lett. 442, 190-194. doi: 10.1016/j.neulet.2008.06.086
43. He, L., Girijashanker, K., Dalton, T. P., Reed, J., Li, H., Soleimani, M.,et al. (2006). ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties. Mol. Pharmacol. 70, 171-180. doi: 10.1124/mol.106.024521
44. He, Q., Du, T., Yu, X., Xie, A., Song, N., Kang, Q.,et al. (2011). DMT1 polymorphism and risk of Parkinson's disease. Neurosci. Lett. 501, 128-131. doi: 10.1016/j.neulet.2011.07.001
45. Hermanson, E., Joseph, B., Castro, D., Lindqvist, E., Aarnisalo, P., Wallén, Å.,et al. (2003). Nurr1 regulates dopamine synthesis and storage in MN9D dopamine cells. Exp. Cell Res. 288, 324-334. doi: 10.1016/S0014-4827(03)00216-7
46. Himeno, S., Yanagiya, T., and Fujishiro, H. (2009). The role of zinc transporters in cadmium and manganese transport in mammalian cells. Biochimie 91, 1218-1222. doi: 10.1016/j.biochi.2009.04.002
47. Hod, Y., Pentyala, S. N., Whyard, T. C., and El-Maghrabi, M. R. (1999). Identification and characterization of a novel protein that regulates RNA-protein interaction. J. Cell. Biochem. 72, 435-444. doi: 10.1002/(SICI)1097-4644(19990301)72:3<435::AID-JCB12>3.0.CO;2-H
48. Hsu, L. J., Sagara, Y., Arroyo, A., Rockenstein, E., Sisk, A., Mallory, M.,et al. (2000). α-synuclein promotes mitochondrial deficit and oxidative stress. Am. J. Pathol. 157, 401-410. doi: 10.1016/S0002-9440(10)64553-1
49. Huang, C. C., Chu, N. S., Lu, C. S., Chen, R. S., and Calne, D. B. (1998). Long-term progression in chronic manganism: ten years of follow-up. Neurology 50, 698-700. doi: 10.1212/WNL.50.3.698
50. Huang, C. C., Chu, N. S., Lu, C. S., Chen, R. S., Schulzer, M., and Calne, D. B. (2007). The natural history of neurological manganism over 18 years. Parkinsonism Relat. Disord. 13, 143-145. doi: 10.1016/j.parkreldis.2006.09.002
51. Huang, C. C., Chu, N. S., Lu, C. S., Wang, J. D., Tsai, J. L., Tzeng, J. L.,et al. (1989). Chronic manganese intoxication. Arch. Neurol. 46, 1104-1106. doi: 10.1001/archneur.1989.00520460090018
52. Huang, C. C., Lu, C. S., Chu, N. S., Hochberg, F., Lilienfeld, D., Olanow, W.,et al. (1993). Progression after chronic manganese exposure. Neurology 43, 1479-1483. doi: 10.1212/WNL.43.8.1479
53. Huang, E., Ong, W. Y., and Connor, J. R. (2004). Distribution of divalent metal transporter-1 in the monkey basal ganglia. Neuroscience 128, 487-496. doi: 10.1016/j.neuroscience.2004.06.055
54. Ikeda, S., Yamaguchi, Y., Sera, Y., Ohshiro, H., Uchino, S., Yamashita, Y.,et al. (2000). Manganese deposition in the globus pallidus in patients with biliary atresia. Transplantation 69, 2339-2343. doi: 10.1097/00007890-200006150-00021
55. Ingersoll, R. T., Montgomery, E. B., and Aposhian, H. V. (1999). Central nervous system toxicity of manganese. II. Cocaine or reserpine inhibit manganese concentration in the rat brain. Neurotoxicology 20, 467-476.
56. Inoue, E., Hori, S., Narumi, Y., Fujita, M., Kuriyama, K., Kadota, T.,et al. (1991). Portal-systemic encephalopathy: presence of basal ganglia lesions with high signal intensity on MR images. Radiology 179, 551-555. doi: 10.1148/radiology.179.2.2014310
57. Jankovic, J., Chen, S., and Le, W. D. (2005). The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease. Prog. Neurobiol. 77, 128-138. doi: 10.1016/j.pneurobio.2005.09.001
58. Jellinger, K. A. (2012). Neuropathology of sporadic Parkinson's disease: evaluation and changes of concepts. Mov. Disord. 27, 8-30. doi: 10.1002/mds.23795
59. Jorge da Silva, C., José Da Rocha, A., Mendes, M., Braga, A., and Jeronymo, S. (2008). Brain manganese deposition depicted by magnetic resonance imaging in a welder. Arch. Neurol. 65, 983-983. doi: 10.1001/archneur.65.7.983
60. Keen, C. L., Bell, J. G., and Lonnerdal, B. (1986). The effect of age on manganese uptake and retention from milk and infant formulas in rats. J. Nutr. 116, 395-402.
61. Koller, W. C., Lyons, K. E., and Truly, W. (2004). Effect of levodopa treatment for parkinsonism in welders: a double-blind study. Neurology 62, 730-733. doi: 10.1212/01.WNL.0000113726.34734.15
62. Kulisevsky, J., Pujol, J., Balanzo, J., Junque, C., Deus, J., Capdevilla, A.,et al. (1992). Pallidal hyperintensity on magnetic resonance imaging in cirrhotic patients: clinical correlations. Hepatology 16, 1382-1388. doi: 10.1002/hep.1840160613
63. Kuwahara, T., Koyama, A., Gengyo-Ando, K., Masuda, M., Kowa, H., Tsunoda, M.,et al. (2006). Familial Parkinson mutant α-synuclein causes dopamine neuron dysfunction in transgenic Caenorhabditis elegans . J. Biol. Chem. 281, 334-340. doi: 10.1074/jbc.M504860200
64. Lansbury, P. T. Jr. (2006). Improving synaptic function in a mouse model of AD. Cell 126, 655-657. doi: 10.1016/j.cell.2006.08.011
65. Liu, Y., Fallon, L., Lashuel, H. A., Liu, Z., and Lansbury, P. T. Jr. (2002). The UCH-L1 gene encodes two opposing enzymatic activities that affect α-synuclein degradation and Parkinson's disease susceptibility. Cell 111, 209-218. doi: 10.1016/S0092-8674(02)01012-7
66. Lockman, P. R., Roder, K. E., and Allen, D. D. (2001). Inhibition of the rat blood-brain barrier choline transporter by manganese chloride. J. Neurochem. 79, 588-594. doi: 10.1046/j.1471-4159.2001.00589.x
67. Lucaciu, C. M., Dragu, C., Copaescu, L., and Morariu, V. V. (1997). Manganese transport through human erythrocyte membranes. An EPR study. Biochim. Biophys. Acta 1328, 90-98. doi: 10.1016/S0005-2736(97)00039-4
68. Lucchini, R., Albini, E., Placidi, D., Gasparotti, R., Pigozzi, M. G., Montani, G.,et al. (2000). Brain magnetic resonance imaging and manganese exposure. Neurotoxicology 21, 769-775.
69. Lucchini, R. G., Albini, E., Benedetti, L., Borghesi, S., Coccaglio, R., Malara, E. C.,et al. (2007). High prevalence of Parkinsonian disorders associated to manganese exposure in the vicinities of ferroalloy industries. Am. J. Ind. Med. 50, 788-800. doi: 10.1002/ajim.20494
70. Madejczyk, M. S., and Ballatori, N. (2012). The iron transporter ferroportin can also function as a manganese exporter. Biochim. Biophys. Acta 1818, 651-657. doi: 10.1016/j.bbamem.2011.12.002
71. Malecki, E. A., Radzanowski, G. M., Radzanowski, T. J., Gallaher, D. D., and Greger, J. L. (1996). Biliary manganese excretion in conscious rats is affected by acute and chronic manganese intake but not by dietary fat. J. Nutr. 126, 489-498.
72. Masliah, E., Rockenstein, E., Veinbergs, I., Mallory, M., Hashimoto, M., Takeda, A.,et al. (2000). Dopaminergic loss and inclusion body formation in α-synuclein mice: implications for neurodegenerative disorders. Science 287, 1265-1269. doi: 10.1126/science.287.5456.1265
73. Mason, R. P. (1993). Membrane interaction of calcium channel antagonists modulated by cholesterol. Implications for drug activity. Biochem. Pharmacol. 45, 2173-2183. doi: 10.1016/0006-2952(93)90186-Z
74. McCord, J. M. (1976). Iron- and manganese-containing superoxide dismutases: structure, distribution, and evolutionary relationships. Adv. Exp. Med. Biol. 74, 540-550. doi: 10.1007/978-1-4684-3270-1_45
75. Mena, I., Marin, O., Fuenzalida, S., and Cotzias, G. C. (1967). Chronic manganese poisoning. Clinical picture and manganese turnover. Neurology 17, 128-136. doi: 10.1212/WNL.17.2.128
76. Meray, R. K., and Lansbury, P. T. (2007). Reversible monoubiquitination regulates the Parkinson disease-associated ubiquitin hydrolase UCH-L1. J. Biol. Chem. 282, 10567-10575. doi: 10.1074/jbc.M611153200
77. Mitsumoto, A., and Nakagawa, Y. (2001). DJ-1 is an indicator for endogenous reactive oxygen species elicited by endotoxin. Free Radic. Res. 35, 885-893. doi: 10.1080/10715760100301381
78. Mitsumoto, A., Nakagawa, Y., Takeuchi, A., Okawa, K., Iwamatsu, A., and Takanezawa, Y. (2001). Oxidized forms of peroxiredoxins and DJ-1 on two-dimensional gels increased in response to sublethal levels of paraquat. Free Radic. Res. 35, 301-310. doi: 10.1080/10715760100300831
79. Morris, C. M., Keith, A. B., Edwardson, J. A., and Pullen, R. G. (1992). Uptake and distribution of iron and transferrin in the adult rat brain. J. Neurochem. 59, 300-306. doi: 10.1111/j.1471-4159.1992.tb08904.x
80. 2+ATPase (SPCA1) in neuronal and glial cell cultures. Cell. Mol. Neurobiol. 26, 1355-1365. doi: 10.1007/s10571-006-9042-z
81. Narhi, L., Wood, S. J., Steavenson, S., Jiang, Y., Wu, G. M., Anafi, D.,et al. (1999). Both familial Parkinson's disease mutations accelerate α-synuclein aggregation. J. Biol. Chem. 274, 9843-9846. doi: 10.1074/jbc.274.14.9843
82. Newland, M. C., Ceckler, T. L., Kordower, J. H., and Weiss, B. (1989). Visualizing manganese in the primate basal ganglia with magnetic resonance imaging. Exp. Neurol. 106, 251-258. doi: 10.1016/0014-4886(89)90157-X
83. Parkinson, J. (2002). An essay on the shaking palsy. 1817. J. Neuropsychiatry Clin. Neurosci. 14, 223-236; discussion 222. doi: 10.1176/appi.neuropsych.14.2.223
84. Petrucelli, L., O'arrell, C., Lockhart, P. J., Baptista, M., Kehoe, K., Vink, L.,et al. (2002). Parkin protects against the toxicity associated with mutant α-synuclein: proteasome dysfunction selectively affects catecholaminergic neurons. Neuron 36, 1007-1019. doi: 10.1016/S0896-6273(02)01125-X
85. Pujol, A., Pujol, J., Graus, F., Rimola, A., Peri, J., Mercader, J. M.,et al. (1993). Hyperintense globus pallidus on T1-weighted MRI in cirrhotic patients is associated with severity of liver failure. Neurology 43, 65-69. doi: 10.1212/WNL.43.1_Part_1.65
86. Quadri, M., Federico, A., Zhao, T., Breedveld, G. J., Battisti, C., Delnooz, C.,et al. (2012). Mutations in SLC30A10 cause parkinsonism and dystonia with hypermanganesemia, polycythemia, and chronic liver disease. Am. J. Hum. Genet. 90, 467-477. doi: 10.1016/j.ajhg.2012.01.017
87. Racette, B. A. (2013). Manganism in the 21st century: the Hanninen lecture. Neurotoxicology doi: 10.1016/j.neuro.2013.09.007 [Epub ahead of print].
88. Racette, B. A., Criswell, S. R., Lundin, J. I., Hobson, A., Seixas, N., Kotzbauer, P. T.,et al. (2012). Increased risk of parkinsonism associated with welding exposure. Neurotoxicology 33, 1356-1361. doi: 10.1016/j.neuro.2012.08.011
89. Racette, B. A., Mcgee-Minnich, L., Moerlein, S. M., Mink, J. W., Videen, T. O., and Perlmutter, J. S. (2001). Welding-related parkinsonism: clinical features, treatment, and pathophysiology. Neurology 56, 8-13. doi: 10.1212/WNL.56.1.8
90. Rodier, J. (1955). Manganese poisoning in Moroccan miners. Br. J. Ind. Med. 12, 21-35. doi: 10.1136/oem.12.1.21
91. Roholt, O. A. Jr., and Greenberg, D. M. (1956). Liver arginase. IV. Effect of pH on kinetics of manganese-activated enzyme. Arch. Biochem. Biophys. 62, 454-470. doi: 10.1016/0003-9861(56)90144-8
92. Rose, C., Butterworth, R. F., Zayed, J., Normandin, L., Todd, K., Michalak, A.,et al. (1999). Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 117, 640-644. doi: 10.1016/S0016-5085(99)70457-9
93. Roth, J. A. (2009). Are there common biochemical and molecular mechanisms controlling manganism and parkisonism. Neuromolecular Med. 11, 281-296. doi: 10.1007/s12017-009-8088-8
94. Sacchetti, P., Mitchell, T. R., Granneman, J. G., and Bannon, M. J. (2001). Nurr1 enhances transcription of the human dopamine transporter gene through a novel mechanism. J. Neurochem. 76, 1565-1572. doi: 10.1046/j.1471-4159.2001.00181.x
95. Sakurada, K., Ohshima-Sakurada, M., Palmer, T. D., and Gage, F. H. (1999). Nurr1, an orphan nuclear receptor, is a transcriptional activator of endogenous tyrosine hydroxylase in neural progenitor cells derived from the adult brain. Development 126, 4017-4026.
96. Salazar, J., Mena, N., Hunot, S., Prigent, A., Alvarez-Fischer, D., Arredondo, M.,et al. (2008). Divalent metal transporter 1 (DMT1) contributes to neurodegeneration in animal models of Parkinson's disease. Proc. Natl. Acad. Sci. U.S.A. 105, 18578-18583. doi: 10.1073/pnas.0804373105
97. Sandstead, H. H. (1986). A brief history of the influence of trace elements on brain function. Am. J. Clin. Nutr. 43, 293-298.
98. Seve, M., Chimienti, F., Devergnas, S., and Favier, A. (2004). In silico identification and expression of SLC30 family genes: an expressed sequence tag data mining strategy for the characterization of zinc transporters' tissue expression. BMC Genomics 5:32. doi: 10.1186/1471-2164-5-32
99. Shendelman, S., Jonason, A., Martinat, C., Leete, T., and Abeliovich, A. (2004). DJ-1 is a redox-dependent molecular chaperone that inhibits α-synuclein aggregate formation. PLoS Biol. 2:e362. doi: 10.1371/journal.pbio.0020362
100. Shimura, H., Hattori, N., Kubo, S.-I., Mizuno, Y., Asakawa, S., Minoshima, S.,et al. (2000). Familial Parkinson disease gene product, parkin, is a ubiquitin-protein ligase. Nat. Genet. 25, 302-305. doi: 10.1038/77060
101. Shinotoh, H., Snow, B. J., Chu, N. S., Huang, C. C., Lu, C. S., Lee, C.,et al. (1997). Presynaptic and postsynaptic striatal dopaminergic function in patients with manganese intoxication: a positron emission tomography study. Neurology 48, 1053-1056. doi: 10.1212/WNL.48.4.1053
102. Sikk, K., Haldre, S., Aquilonius, S. M., Asser, A., Paris, M., Roose, Ä.,et al. (2013). Manganese-induced parkinsonism in methcathinone abusers: bio-markers of exposure and follow-up. Eur. J. Neurol. 20, 915-920. doi: 10.1111/ene.12088
103. Smialowicz, R. J., Luebke, R. W., Rogers, R. R., Riddle, M. M., and Rowe, D. G. (1985). Manganese chloride enhances natural cell-mediated immune effector cell function: effects on macrophages. Immunopharmacology 9, 1-11. doi: 10.1016/0162-3109(85)90040-2
104. Smith, E. A., Newland, P., Bestwick, K. G., and Ahmed, N. (2012). Increased whole blood manganese concentrations observed in children with iron deficiency anaemia. J. Trace Elem. Med. Biol. 27, 65-69. doi: 10.1016/j.jtemb.2012.07.002
105. Smith, W. W., Pei, Z., Jiang, H., Moore, D. J., Liang, Y., West, A. B.,et al. (2005). Leucine-rich repeat kinase 2 (LRRK2) interacts with parkin, and mutant LRRK2 induces neuronal degeneration. Proc. Natl. Acad. Sci. U.S.A. 102, 18676-18681. doi: 10.1073/pnas.0508052102
106. Sossi, V., De La Fuente-Fernández, R., Schulzer, M., Troiano, A. R., Ruth, T. J., and Stoessl, A. J. (2007). Dopamine transporter relation to dopamine turnover in Parkinson's disease: a positron emission tomography study. Ann. Neurol. 62, 468-474. doi: 10.1002/ana.21204
107. Stamelou, M., Tuschl, K., Chong, W. K., Burroughs, A. K., Mills, P. B., Bhatia, K. P.,et al. (2012). Dystonia with brain manganese accumulation resulting from SLC30A10 mutations: a new treatable disorder. Mov. Disord. 27, 1317-1322. doi: 10.1002/mds.25138
108. Suzuki, N., Nakamura, Y., Kobayashi, N., and Sato, T. (1975). On metal elements in pure pigment gallstones. Tohoku J. Exp. Med. 116, 233-240. doi: 10.1620/tjem.116.233
109. Takahashi, K., Taira, T., Niki, T., Seino, C., Iguchi-Ariga, S. M. M., and Ariga, H. (2001). DJ-1 positively regulates the androgen receptor by impairing the binding of PIASxα to the receptor. J. Biol. Chem. 276, 37556-37563. doi: 10.1074/jbc.M101730200
110. Tan, J., Zhang, T., Jiang, L., Chi, J., Hu, D., Pan, Q.,et al. (2011). Regulation of intracellular manganese homeostasis by Kufor-Rakeb syndrome-associated ATP13A2 protein. J. Biol. Chem. 286, 29654-29662. doi: 10.1074/jbc.M111.233874
111. Tuschl, K., Clayton, P. T., Gospe, S. M. Jr., Gulab, S., Ibrahim, S., Singhi, P.,et al. (2012). Syndrome of hepatic cirrhosis, dystonia, polycythemia, and hypermanganesemia caused by mutations in SLC30A10, a manganese transporter in man. Am. J. Hum. Genet. 90, 457-466. doi: 10.1016/j.ajhg.2012.01.018
112. Urrutia, P., Aguirre, P., Esparza, A., Tapia, V., Mena, N. P., Arredondo, M.,et al. (2013). Inflammation alters the expression of DMT1, FPN1 and hepcidin, and it causes iron accumulation in central nervous system cells. J. Neurochem. 126, 541-549. doi: 10.1111/jnc.12244
113. Valente, E. M., Abou-Sleiman, P. M., Caputo, V., Muqit, M. M. K., Harvey, K., Gispert, S.,et al. (2004). Hereditary early-onset Parkinson's disease caused by mutations in PINK1. Science 304, 1158-1160. doi: 10.1126/science.1096284
114. Wedler, F. C., and Denman, R. B. (1984). Glutamine synthetase: the major Mn(II) enzyme in mammalian brain. Curr. Top. Cell. Regul. 24, 153-169. doi: 10.1016/B978-0-12-152824-9.50021-6
115. Weissenborn, K., Ehrenheim, C., Hori, A., Kubicka, S., and Manns, M. P. (1995). Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluation. Metab. Brain Dis. 10, 219-231. doi: 10.1007/BF02081027
116. Wilkinson, K. D. (2000). Ubiquitination and deubiquitination: targeting of proteins for degradation by the proteasome. Semin. Cell Dev. Biol . 11, 141-148. doi: 10.1006/scdb.2000.0164
117. Williams, K., Wilson, M. A., and Bressler, J. (2000). Regulation and developmental expression of the divalent metal-ion transporter in the rat brain. Cell. Mol. Biol. (Noisy-le-grand) 46, 563-571.
118. Yang, Y., Gehrke, S., Imai, Y., Huang, Z., Ouyang, Y., Wang, J.-W.,et al. (2006). Mitochondrial pathology and muscle and dopaminergic neuron degeneration caused by inactivation of Drosophila Pink1 is rescued by Parkin. Proc. Natl. Acad. Sci. U.S.A. 103, 10793-10798. doi: 10.1073/pnas.0602493103
119. Yang, Y., Nishimura, I., Imai, Y., Takahashi, R., and Lu, B. (2003). Parkin suppresses dopaminergic neuron-selective neurotoxicity induced by Pael-R in drosophila. Neuron 37, 911-924. doi: 10.1016/S0896-6273(03)00143-0
120. Yin, Z., Jiang, H., Lee, E. S., Ni, M., Erikson, K. M., Milatovic, D.,et al. (2010). Ferroportin is a manganese-responsive protein that decreases manganese cytotoxicity and accumulation. J. Neurochem. 112, 1190-1198. doi: 10.1111/j.1471-4159.2009.06534.x
121. Zhou, C., Huang, Y., Shao, Y., May, J., Prou, D., Perier, C.,et al. (2008). The kinase domain of mitochondrial PINK1 faces the cytoplasm. Proc. Natl. Acad. Sci. U.S.A. 105, 12022-12027. doi: 10.1073/pnas.0802814105
122. Zhou, Z. D., Kerk, S. Y., Xiong, G. G., and Lim, T. M. (2009). Dopamine auto-oxidation aggravates non-apoptotic cell death induced by over-expression of human A53T mutant alpha-synuclein in dopaminergic PC12 cells. J. Neurochem. 108, 601-610. doi: 10.1111/j.1471-4159.2008.05795.x
123. Zlotkin, S. H., Atkinson, S., and Lockitch, G. (1995). Trace elements in nutrition for premature infants. Clin. Perinatol. 22, 223-240.